New Once-a-Day pill could ease lifelong burden of rare copper disease
NCT ID NCT07465718
Summary
This study is testing a new, once-daily version of a copper-removing drug (trientine) against the current standard treatment (d-Penicillamine) for people newly diagnosed with Wilson's disease. It aims to see if the new formulation is effective, safe, and easier to stick with than treatments taken multiple times a day. The trial will enroll about 38 children (8+) and adults who have not yet started standard copper-removing therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WILSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.